Prediction of Acute Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy Using Dose-Volume Parameters From Functional Mapping on Gallium 68 Perfusion Positron Emission Tomography/Computed Tomography
The aim of this work was to compare anatomic and functional dose-volume parameters as predictors of acute radiation-induced lung toxicity (RILT) in patients with lung tumors treated with stereotactic body radiation therapy. Fifty-nine patients treated with stereotactic body radiation therapy were pr...
Saved in:
Published in | International journal of radiation oncology, biology, physics Vol. 118; no. 4; pp. 952 - 962 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
15.03.2024
|
Online Access | Get full text |
Cover
Loading…
Abstract | The aim of this work was to compare anatomic and functional dose-volume parameters as predictors of acute radiation-induced lung toxicity (RILT) in patients with lung tumors treated with stereotactic body radiation therapy.
Fifty-nine patients treated with stereotactic body radiation therapy were prospectively included. All patients underwent gallium 68 lung perfusion positron emission tomography (PET)/computed tomography (CT) imaging before treatment. Mean lung dose (MLD) and volumes receiving x Gy (VxGy, 5-30 Gy) were calculated in 5 lung volumes: the conventional anatomic volume (AV) delineated on CT images, 3 lung functional volumes (FVs) defined on lung perfusion PET imaging (FV50%, FV70%, and FV90%; ie, the minimal volume containing 50%, 70%, and 90% of the total activity within the AV), and a low FV (LFV; LFV = AV − FV90%). The primary endpoint of this analysis was grade ≥2 acute RILT at 3 months as assessed with National Cancer Institute Common Terminology Criteria for Adverse Events version 5. Dose-volume parameters in patients with and without acute RILT were compared. Receiver operating characteristic curves assessing the ability of dose-volume parameters to discriminate between patients with and without acute RILT were generated, and area under the curve (AUC) values were calculated.
Of the 59 patients, 10 (17%) had grade ≥2 acute RILT. The MLD and the VxGy in the AV and LFV were not statistically different between patients with and without acute RILT (P > .05). All functional parameters were significantly higher in acute RILT patients (P < .05). AUC values (95% CI) for MLD AV, LFV, FV50%, FV70%, and FV90% were 0.66 (0.46-0.85), 0.60 (0.39-0.80), 0.77 (0.63-0.91), 0.77 (0.64-0.91), and 0.75 (0.58-0.91), respectively. AUC values for V20Gy AV, LFV, FV50%, FV70%, and FV90% were 0.65 (0.44-0.87), 0.64 (0.46-0.83), 0.82 (0.69-0.95), 0.81 (0.67-0.96), and 0.75 (0.57-0.94), respectively.
The predictive value of PET perfusion-based functional parameters outperforms the standard CT-based dose-volume parameters for the risk of grade ≥2 acute RILT. Functional parameters could be useful for guiding radiation therapy planning and reducing the risk of acute RILT. |
---|---|
AbstractList | PURPOSEThe aim of this work was to compare anatomic and functional dose-volume parameters as predictors of acute radiation-induced lung toxicity (RILT) in patients with lung tumors treated with stereotactic body radiation therapy.METHODS AND MATERIALSFifty-nine patients treated with stereotactic body radiation therapy were prospectively included. All patients underwent gallium 68 lung perfusion positron emission tomography (PET)/computed tomography (CT) imaging before treatment. Mean lung dose (MLD) and volumes receiving x Gy (VxGy, 5-30 Gy) were calculated in 5 lung volumes: the conventional anatomic volume (AV) delineated on CT images, 3 lung functional volumes (FVs) defined on lung perfusion PET imaging (FV50%, FV70%, and FV90%; ie, the minimal volume containing 50%, 70%, and 90% of the total activity within the AV), and a low FV (LFV; LFV = AV - FV90%). The primary endpoint of this analysis was grade ≥2 acute RILT at 3 months as assessed with National Cancer Institute Common Terminology Criteria for Adverse Events version 5. Dose-volume parameters in patients with and without acute RILT were compared. Receiver operating characteristic curves assessing the ability of dose-volume parameters to discriminate between patients with and without acute RILT were generated, and area under the curve (AUC) values were calculated.RESULTSOf the 59 patients, 10 (17%) had grade ≥2 acute RILT. The MLD and the VxGy in the AV and LFV were not statistically different between patients with and without acute RILT (P > .05). All functional parameters were significantly higher in acute RILT patients (P < .05). AUC values (95% CI) for MLD AV, LFV, FV50%, FV70%, and FV90% were 0.66 (0.46-0.85), 0.60 (0.39-0.80), 0.77 (0.63-0.91), 0.77 (0.64-0.91), and 0.75 (0.58-0.91), respectively. AUC values for V20Gy AV, LFV, FV50%, FV70%, and FV90% were 0.65 (0.44-0.87), 0.64 (0.46-0.83), 0.82 (0.69-0.95), 0.81 (0.67-0.96), and 0.75 (0.57-0.94), respectively.CONCLUSIONSThe predictive value of PET perfusion-based functional parameters outperforms the standard CT-based dose-volume parameters for the risk of grade ≥2 acute RILT. Functional parameters could be useful for guiding radiation therapy planning and reducing the risk of acute RILT. The aim of this work was to compare anatomic and functional dose-volume parameters as predictors of acute radiation-induced lung toxicity (RILT) in patients with lung tumors treated with stereotactic body radiation therapy. Fifty-nine patients treated with stereotactic body radiation therapy were prospectively included. All patients underwent gallium 68 lung perfusion positron emission tomography (PET)/computed tomography (CT) imaging before treatment. Mean lung dose (MLD) and volumes receiving x Gy (VxGy, 5-30 Gy) were calculated in 5 lung volumes: the conventional anatomic volume (AV) delineated on CT images, 3 lung functional volumes (FVs) defined on lung perfusion PET imaging (FV50%, FV70%, and FV90%; ie, the minimal volume containing 50%, 70%, and 90% of the total activity within the AV), and a low FV (LFV; LFV = AV - FV90%). The primary endpoint of this analysis was grade ≥2 acute RILT at 3 months as assessed with National Cancer Institute Common Terminology Criteria for Adverse Events version 5. Dose-volume parameters in patients with and without acute RILT were compared. Receiver operating characteristic curves assessing the ability of dose-volume parameters to discriminate between patients with and without acute RILT were generated, and area under the curve (AUC) values were calculated. Of the 59 patients, 10 (17%) had grade ≥2 acute RILT. The MLD and the VxGy in the AV and LFV were not statistically different between patients with and without acute RILT (P > .05). All functional parameters were significantly higher in acute RILT patients (P < .05). AUC values (95% CI) for MLD AV, LFV, FV50%, FV70%, and FV90% were 0.66 (0.46-0.85), 0.60 (0.39-0.80), 0.77 (0.63-0.91), 0.77 (0.64-0.91), and 0.75 (0.58-0.91), respectively. AUC values for V20Gy AV, LFV, FV50%, FV70%, and FV90% were 0.65 (0.44-0.87), 0.64 (0.46-0.83), 0.82 (0.69-0.95), 0.81 (0.67-0.96), and 0.75 (0.57-0.94), respectively. The predictive value of PET perfusion-based functional parameters outperforms the standard CT-based dose-volume parameters for the risk of grade ≥2 acute RILT. Functional parameters could be useful for guiding radiation therapy planning and reducing the risk of acute RILT. The aim of this work was to compare anatomic and functional dose-volume parameters as predictors of acute radiation-induced lung toxicity (RILT) in patients with lung tumors treated with stereotactic body radiation therapy. Fifty-nine patients treated with stereotactic body radiation therapy were prospectively included. All patients underwent gallium 68 lung perfusion positron emission tomography (PET)/computed tomography (CT) imaging before treatment. Mean lung dose (MLD) and volumes receiving x Gy (VxGy, 5-30 Gy) were calculated in 5 lung volumes: the conventional anatomic volume (AV) delineated on CT images, 3 lung functional volumes (FVs) defined on lung perfusion PET imaging (FV50%, FV70%, and FV90%; ie, the minimal volume containing 50%, 70%, and 90% of the total activity within the AV), and a low FV (LFV; LFV = AV − FV90%). The primary endpoint of this analysis was grade ≥2 acute RILT at 3 months as assessed with National Cancer Institute Common Terminology Criteria for Adverse Events version 5. Dose-volume parameters in patients with and without acute RILT were compared. Receiver operating characteristic curves assessing the ability of dose-volume parameters to discriminate between patients with and without acute RILT were generated, and area under the curve (AUC) values were calculated. Of the 59 patients, 10 (17%) had grade ≥2 acute RILT. The MLD and the VxGy in the AV and LFV were not statistically different between patients with and without acute RILT (P > .05). All functional parameters were significantly higher in acute RILT patients (P < .05). AUC values (95% CI) for MLD AV, LFV, FV50%, FV70%, and FV90% were 0.66 (0.46-0.85), 0.60 (0.39-0.80), 0.77 (0.63-0.91), 0.77 (0.64-0.91), and 0.75 (0.58-0.91), respectively. AUC values for V20Gy AV, LFV, FV50%, FV70%, and FV90% were 0.65 (0.44-0.87), 0.64 (0.46-0.83), 0.82 (0.69-0.95), 0.81 (0.67-0.96), and 0.75 (0.57-0.94), respectively. The predictive value of PET perfusion-based functional parameters outperforms the standard CT-based dose-volume parameters for the risk of grade ≥2 acute RILT. Functional parameters could be useful for guiding radiation therapy planning and reducing the risk of acute RILT. |
Author | Blanc-Béguin, Frédérique Lucia, François Kerleguer, Kevin Le Roux, Pierre-Yves Goasduff, Gaëlle Pradier, Olivier Le Gal, Grégoire Salaun, Pierre-Yves Hamya, Mohamed Schick, Ulrike Mauguen, Maëlle Bourhis, David Bourbonne, Vincent Pinot, Fanny Consigny, Maëlys Hennebicq, Simon |
Author_xml | – sequence: 1 givenname: François surname: Lucia fullname: Lucia, François email: francois.lucia@chu-brest.fr organization: Radiation Oncology Department, University Hospital, Brest, France – sequence: 2 givenname: David surname: Bourhis fullname: Bourhis, David organization: Service de Médecine Nucléaire, CHRU de Brest, Brest, France – sequence: 3 givenname: Fanny surname: Pinot fullname: Pinot, Fanny organization: Service de Médecine Nucléaire, CHRU de Brest, Brest, France – sequence: 4 givenname: Mohamed surname: Hamya fullname: Hamya, Mohamed organization: LaTIM, INSERM, UMR 1101, University of Brest, Brest, France – sequence: 5 givenname: Gaëlle surname: Goasduff fullname: Goasduff, Gaëlle organization: LaTIM, INSERM, UMR 1101, University of Brest, Brest, France – sequence: 6 givenname: Frédérique surname: Blanc-Béguin fullname: Blanc-Béguin, Frédérique organization: Service de Médecine Nucléaire, CHRU de Brest, Brest, France – sequence: 7 givenname: Simon surname: Hennebicq fullname: Hennebicq, Simon organization: Service de Médecine Nucléaire, CHRU de Brest, Brest, France – sequence: 8 givenname: Maëlle surname: Mauguen fullname: Mauguen, Maëlle organization: Radiation Oncology Department, University Hospital, Brest, France – sequence: 9 givenname: Kevin surname: Kerleguer fullname: Kerleguer, Kevin organization: Service de Médecine Nucléaire, CHRU de Brest, Brest, France – sequence: 10 givenname: Ulrike surname: Schick fullname: Schick, Ulrike organization: Radiation Oncology Department, University Hospital, Brest, France – sequence: 11 givenname: Maëlys surname: Consigny fullname: Consigny, Maëlys organization: Direction de la Recherche Clinique et de l'Innovation (DRCI), CHU Brest, Brest, France – sequence: 12 givenname: Olivier surname: Pradier fullname: Pradier, Olivier organization: Radiation Oncology Department, University Hospital, Brest, France – sequence: 13 givenname: Grégoire surname: Le Gal fullname: Le Gal, Grégoire organization: Department of Medicine, Ottawa Hospital Research Institute at the University of Ottawa, Ottawa, Ontario, Canada – sequence: 14 givenname: Pierre-Yves surname: Salaun fullname: Salaun, Pierre-Yves organization: Service de Médecine Nucléaire, CHRU de Brest, Brest, France – sequence: 15 givenname: Vincent surname: Bourbonne fullname: Bourbonne, Vincent organization: Radiation Oncology Department, University Hospital, Brest, France – sequence: 16 givenname: Pierre-Yves surname: Le Roux fullname: Le Roux, Pierre-Yves email: pierre-yves.leroux@chu-brest.fr organization: Service de Médecine Nucléaire, CHRU de Brest, Brest, France |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37875246$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kV9v0zAUxS00xLrBN0DIj7yks-PESV-QSlnHpCIq6BBvlmtfb66SONgxIp91X2bOOv488WJbR-d3z7XOGTrpXAcIvaZkTgnlF4e5PXi37-c5yVmS5oQUz9CM1tUiY2X5_QTNCOMkY8l8is5COBBCKK2KF-iUVXVV5gWfofutB23VYF2HncFLFQfAX6S2cpKy605HBRpvYneLd-6XVXYY8dIM4PHXdIAbZIIVfu_0-JfDuzvwsh_xTbAJ_OACZN9cE1vAW-llCwkNeO1di9exe0yXDf4k-36yJ_5KNo2NLeY13oI3MUxDty7YwafHZWvDo7JzrbtNQXfjxcq1fdpd_6O9RM-NbAK8errP0c36crf6mG0-X12vlptMsbIaMm4YpUbnpVZ1Xi8WipOqIEZSYHShpdSUS8P2isiiIFIBJ6pQvNZasxyM3LNz9PY4t_fuR4QwiLSfgqaRHbgYRF7XtKKEl1WyFker8i4ED0b03rbSj4ISMdUqDuJYq5hqndRUa8LePCXEfQv6D_S7x2R4dzRA-udPC14EZaFL1VkPahDa2f8nPADd773f |
Cites_doi | 10.1002/cncr.26611 10.3390/cancers15072166 10.1118/1.4937599 10.1177/1533034614565534 10.1097/COC.0b013e3181979238 10.1259/bjr/71635286 10.1053/j.semnuclmed.2016.04.007 10.1007/s11523-016-0459-0 10.1016/j.ijrobp.2011.08.036 10.1001/jama.2010.261 10.3389/fonc.2021.674731 10.1016/j.ijrobp.2018.11.028 10.3390/cancers15061726 10.1016/S0140-6736(18)32487-5 10.1016/j.ijrobp.2016.05.012 10.1007/s00259-019-04338-z 10.1016/j.lungcan.2015.06.019 10.1016/j.ijrobp.2018.05.051 10.1016/j.ijrobp.2012.01.018 10.1016/j.canrad.2021.11.001 10.2967/jnumed.115.162586 10.3390/ph15050518 10.2967/jnumed.111.093344 10.1118/1.4888251 10.1016/S1470-2045(18)30896-9 10.1016/j.radonc.2023.109553 10.1016/j.radonc.2018.07.014 10.1053/j.semnuclmed.2018.10.013 |
ContentType | Journal Article |
Copyright | 2023 Elsevier Inc. Copyright © 2023 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2023 Elsevier Inc. – notice: Copyright © 2023 Elsevier Inc. All rights reserved. |
DBID | NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.ijrobp.2023.10.004 |
DatabaseName | PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1879-355X |
EndPage | 962 |
ExternalDocumentID | 10_1016_j_ijrobp_2023_10_004 37875246 S0360301623080082 |
Genre | Journal Article |
GroupedDBID | --- --K .1- .FO 0R~ 1B1 1P~ 1RT 1~5 4.4 457 4G. 53G 5RE 7-5 AAEDT AAEDW AAIAV AALRI AAWTL AAXUO ABJNI ABLJU ABNEU ABOCM ABUDA ACGFS ACIUM ADBBV AENEX AEVXI AFCTW AFRHN AFTJW AGZHU AHHHB AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS ALXNB AMRAJ BELOY DU5 EBS EFJIC F5P FDB GBLVA HED HMO IHE J1W KOM MO0 O9- OC~ OO- RIG RNS ROL RPZ SDG SEL SES SEW SSZ UV1 XH2 Z5R ZA5 ~S- AFJKZ AKRWK LX3 M41 NPM .55 .GJ 29J 5VS AAQFI AAQQT AAQXK AAYXX ABEFU ADMUD ADPAM ADVLN AFFNX AGRDE ASPBG AVWKF AZFZN CITATION EJD FEDTE FGOYB FIRID G-2 HMK HVGLF HX~ HZ~ NQ- R2- SAE UDS X7M XPP ZGI 7X8 |
ID | FETCH-LOGICAL-c357t-6f311fd25dc82899c60740fa1e319daad16af3bc0a440ace60c4c68ddd32efab3 |
ISSN | 0360-3016 |
IngestDate | Fri Oct 25 08:43:03 EDT 2024 Thu Sep 26 18:25:51 EDT 2024 Sat Nov 02 12:20:43 EDT 2024 Sat Mar 02 16:00:57 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
License | Copyright © 2023 Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c357t-6f311fd25dc82899c60740fa1e319daad16af3bc0a440ace60c4c68ddd32efab3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doi.org/10.1016/j.ijrobp.2023.10.004 |
PMID | 37875246 |
PQID | 2881710657 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_2881710657 crossref_primary_10_1016_j_ijrobp_2023_10_004 pubmed_primary_37875246 elsevier_sciencedirect_doi_10_1016_j_ijrobp_2023_10_004 |
PublicationCentury | 2000 |
PublicationDate | 2024-03-15 |
PublicationDateYYYYMMDD | 2024-03-15 |
PublicationDate_xml | – month: 03 year: 2024 text: 2024-03-15 day: 15 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | International journal of radiation oncology, biology, physics |
PublicationTitleAlternate | Int J Radiat Oncol Biol Phys |
PublicationYear | 2024 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Le Roux, Iravani, Callahan (bib0013) 2019; 46 Berg, Ramberg, Haugstvedt (bib0029) 2021; 11 Hofman, Beauregard, Barber (bib0014) 2011; 52 Palma, Olson, Harrow (bib0002) 2019; 393 National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE). 2017. Available at Siva, Devereux, Ball (bib0027) 2016; 15 Ferrero, Badellino, Filippi (bib0030) 2015; 89 Ball, Mai, Vinod (bib0001) 2019; 20 Kishi, Matsuo, Yoneyama (bib0010) 2022; 7 Su, Liu, Chen (bib0024) 2017; 12 Blanc-Béguin, Hennebicq, Robin (bib0019) 2022; 15 Lee, Zeng, Vesselle (bib0028) 2018; 102 Kipritidis, Hofman, Siva (bib0031) 2016; 43 Timmerman, Paulus, Galvin (bib0005) 2010; 303 Le Roux, Siva, Steinfort (bib0015) 2015; 56 Kadoya, Nakajima, Saito (bib0021) 2016; 96 Pinot, Bourhis, Bourbonne (bib0020) 2023; 15 Nelson, Duchateau, Piper (bib0022) 2014; 41 Lucia, Rehn, Blanc-Béguin (bib0011) 2021; 8 Salama, Hasselle, Chmura (bib0004) 2012; 118 Flakus, Kent, Wallat (bib0032) 2023; 182 Le Roux, Hicks, Siva (bib0017) 2019; 49 Milano, Katz, Okunieff (bib0026) 2010; 33 Bailey, Eslick, Schembri (bib0016) 2016; 46 Noël, Antoni (bib0018) 2022; 26 Milano, Katz, Zhang (bib0003) 2012; 83 Bucknell, Hardcastle, Bressel (bib0012) 2018; 129 Matsuo, Shibuya, Nakamura (bib0009) 2012; 83 Accessed November 10, 2023. Spring Kong, Moiseenko, Zhao (bib0008) 2021; 110 Lucia, Hamya, Pinot (bib0006) 2023; 15 Takeda, Ohashi, Kunieda (bib0007) 2012; 85 Johnson, Cortazar, Chute (bib0025) 1997; 24 Kishi (10.1016/j.ijrobp.2023.10.004_bib0010) 2022; 7 Lucia (10.1016/j.ijrobp.2023.10.004_bib0011) 2021; 8 Milano (10.1016/j.ijrobp.2023.10.004_bib0026) 2010; 33 Lee (10.1016/j.ijrobp.2023.10.004_bib0028) 2018; 102 Kipritidis (10.1016/j.ijrobp.2023.10.004_bib0031) 2016; 43 Ferrero (10.1016/j.ijrobp.2023.10.004_bib0030) 2015; 89 Matsuo (10.1016/j.ijrobp.2023.10.004_bib0009) 2012; 83 Le Roux (10.1016/j.ijrobp.2023.10.004_bib0015) 2015; 56 Flakus (10.1016/j.ijrobp.2023.10.004_bib0032) 2023; 182 Salama (10.1016/j.ijrobp.2023.10.004_bib0004) 2012; 118 Ball (10.1016/j.ijrobp.2023.10.004_bib0001) 2019; 20 Berg (10.1016/j.ijrobp.2023.10.004_bib0029) 2021; 11 Lucia (10.1016/j.ijrobp.2023.10.004_bib0006) 2023; 15 Su (10.1016/j.ijrobp.2023.10.004_bib0024) 2017; 12 Le Roux (10.1016/j.ijrobp.2023.10.004_bib0013) 2019; 46 Siva (10.1016/j.ijrobp.2023.10.004_bib0027) 2016; 15 Bucknell (10.1016/j.ijrobp.2023.10.004_bib0012) 2018; 129 Spring Kong (10.1016/j.ijrobp.2023.10.004_bib0008) 2021; 110 Pinot (10.1016/j.ijrobp.2023.10.004_bib0020) 2023; 15 Takeda (10.1016/j.ijrobp.2023.10.004_bib0007) 2012; 85 Le Roux (10.1016/j.ijrobp.2023.10.004_bib0017) 2019; 49 Timmerman (10.1016/j.ijrobp.2023.10.004_bib0005) 2010; 303 Nelson (10.1016/j.ijrobp.2023.10.004_bib0022) 2014; 41 Palma (10.1016/j.ijrobp.2023.10.004_bib0002) 2019; 393 Kadoya (10.1016/j.ijrobp.2023.10.004_bib0021) 2016; 96 Blanc-Béguin (10.1016/j.ijrobp.2023.10.004_bib0019) 2022; 15 Johnson (10.1016/j.ijrobp.2023.10.004_bib0025) 1997; 24 Bailey (10.1016/j.ijrobp.2023.10.004_bib0016) 2016; 46 Milano (10.1016/j.ijrobp.2023.10.004_bib0003) 2012; 83 Hofman (10.1016/j.ijrobp.2023.10.004_bib0014) 2011; 52 Noël (10.1016/j.ijrobp.2023.10.004_bib0018) 2022; 26 10.1016/j.ijrobp.2023.10.004_bib0023 |
References_xml | – volume: 110 start-page: 172 year: 2021 end-page: 187 ident: bib0008 article-title: Organs at risk considerations for thoracic stereotactic body radiation therapy: What is safe for lung parenchyma? publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Zhao – volume: 303 start-page: 1070 year: 2010 end-page: 1076 ident: bib0005 article-title: Stereotactic body radiation therapy for inoperable early stage lung cancer publication-title: JAMA contributor: fullname: Galvin – volume: 46 start-page: 1596 year: 2019 end-page: 1604 ident: bib0013 article-title: Independent and incremental value of ventilation/perfusion PET/CT and CT pulmonary angiography for pulmonary embolism diagnosis: results of the PECAN pilot study publication-title: Eur J Nucl Med Mol Imaging contributor: fullname: Callahan – volume: 129 start-page: 196 year: 2018 end-page: 208 ident: bib0012 article-title: Functional lung imaging in radiation therapy for lung cancer: A systematic review and meta-analysis publication-title: Radiother Oncol contributor: fullname: Bressel – volume: 11 year: 2021 ident: bib0029 article-title: Lung function after stereotactic body radiation therapy for early-stage non-small cell lung cancer, changes and predictive markers publication-title: Front Oncol contributor: fullname: Haugstvedt – volume: 85 start-page: 636 year: 2012 end-page: 642 ident: bib0007 article-title: Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours publication-title: Br J Radiol contributor: fullname: Kunieda – volume: 41 start-page: 202 year: 2014 ident: bib0022 article-title: SU-E-J-198: Evaluation of a free-form intensity-based deformable registration method using the POPI model publication-title: Med Phys contributor: fullname: Piper – volume: 24 start-page: 492 year: 1997 end-page: 499 ident: bib0025 article-title: Second lung cancers in patients successfully treated for lung cancer publication-title: Semin Oncol contributor: fullname: Chute – volume: 43 start-page: 33 year: 2016 ident: bib0031 article-title: Estimating lung ventilation directly from 4D CT Hounsfield unit values publication-title: Med Phys contributor: fullname: Siva – volume: 182 year: 2023 ident: bib0032 article-title: Metrics of dose to highly ventilated lung are predictive of radiation-induced pneumonitis in lung cancer patients publication-title: Radiother Oncol contributor: fullname: Wallat – volume: 46 start-page: 428 year: 2016 end-page: 435 ident: bib0016 article-title: Ga PET ventilation and perfusion lung imaging-current status and future challenges publication-title: Semin Nucl Med contributor: fullname: Schembri – volume: 33 start-page: 157 year: 2010 end-page: 163 ident: bib0026 article-title: Patterns of recurrence after curative-intent radiation for oligometastases confined to one organ publication-title: Am J Clin Oncol contributor: fullname: Okunieff – volume: 12 start-page: 219 year: 2017 end-page: 227 ident: bib0024 article-title: Risk of second primary malignancies in lung cancer survivors—The influence of different treatments publication-title: Target Oncol contributor: fullname: Chen – volume: 15 start-page: 114 year: 2016 end-page: 121 ident: bib0027 article-title: Ga-68 MAA perfusion 4D-PET/CT scanning allows for functional lung avoidance using conformal radiation therapy planning publication-title: Technol Cancer Res Treat contributor: fullname: Ball – volume: 96 start-page: 422 year: 2016 end-page: 431 ident: bib0021 article-title: Multi-institutional validation study of commercially available deformable image registration software for thoracic images publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Saito – volume: 83 start-page: 878 year: 2012 end-page: 886 ident: bib0003 article-title: Oligometastases treated with stereotactic body radiotherapy: Long-term follow-up of prospective study publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Zhang – volume: 8 year: 2021 ident: bib0011 article-title: Radiation therapy planning of thoracic tumors: A review of challenges associated with lung toxicities and potential perspectives of gallium-68 lung PET/CT imaging publication-title: Front Med (Lausanne) contributor: fullname: Blanc-Béguin – volume: 102 start-page: 1255 year: 2018 end-page: 1264 ident: bib0028 article-title: Correlation of functional lung heterogeneity and dosimetry to radiation pneumonitis using perfusion SPECT/CT and FDG PET/CT imaging publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Vesselle – volume: 15 start-page: 2166 year: 2023 ident: bib0020 article-title: New automated method for lung functional volumes delineation with lung perfusion PET/CT imaging publication-title: Cancers (Basel) contributor: fullname: Bourbonne – volume: 20 start-page: 494 year: 2019 end-page: 503 ident: bib0001 article-title: Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): A phase 3, open-label, randomised controlled trial publication-title: Lancet Oncol contributor: fullname: Vinod – volume: 49 start-page: 71 year: 2019 end-page: 81 ident: bib0017 article-title: PET/CT lung ventilation and perfusion scanning using Galligas and gallium-68-MAA publication-title: Semin Nucl Med contributor: fullname: Siva – volume: 56 start-page: 1718 year: 2015 end-page: 1723 ident: bib0015 article-title: Correlation of publication-title: J Nucl Med contributor: fullname: Steinfort – volume: 15 start-page: 518 year: 2022 ident: bib0019 article-title: Radiopharmaceutical labelling for lung ventilation/perfusion PET/CT imaging: A review of production and optimization processes for clinical use publication-title: Pharmaceuticals (Basel) contributor: fullname: Robin – volume: 15 start-page: 1726 year: 2023 ident: bib0006 article-title: A feasibility study of functional lung volume preservation during stereotactic body radiotherapy guided by gallium-68 perfusion PET/CT publication-title: Cancers contributor: fullname: Pinot – volume: 26 start-page: 59 year: 2022 end-page: 75 ident: bib0018 article-title: Organs at risk radiation dose constraints publication-title: Cancer Radiother contributor: fullname: Antoni – volume: 89 start-page: 350 year: 2015 end-page: 356 ident: bib0030 article-title: Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: A prospective study publication-title: Lung Cancer contributor: fullname: Filippi – volume: 118 start-page: 2962 year: 2012 end-page: 2970 ident: bib0004 article-title: Stereotactic body radiotherapy for multisite extracranial oligometastases publication-title: Cancer contributor: fullname: Chmura – volume: 52 start-page: 1513 year: 2011 end-page: 1519 ident: bib0014 article-title: Ga PET/CT ventilation-perfusion imaging for pulmonary embolism: A pilot study with comparison to conventional scintigraphy publication-title: J Nucl Med contributor: fullname: Barber – volume: 83 start-page: e545 year: 2012 end-page: e549 ident: bib0009 article-title: Dose-volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Nakamura – volume: 393 start-page: 2051 year: 2019 end-page: 2058 ident: bib0002 article-title: Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial publication-title: Lancet contributor: fullname: Harrow – volume: 7 year: 2022 ident: bib0010 article-title: Symptomatic radiation pneumonitis after stereotactic body radiation therapy for multiple pulmonary oligometastases or synchronous primary lung cancer publication-title: Adv Radiat Oncol contributor: fullname: Yoneyama – volume: 118 start-page: 2962 year: 2012 ident: 10.1016/j.ijrobp.2023.10.004_bib0004 article-title: Stereotactic body radiotherapy for multisite extracranial oligometastases publication-title: Cancer doi: 10.1002/cncr.26611 contributor: fullname: Salama – volume: 15 start-page: 2166 year: 2023 ident: 10.1016/j.ijrobp.2023.10.004_bib0020 article-title: New automated method for lung functional volumes delineation with lung perfusion PET/CT imaging publication-title: Cancers (Basel) doi: 10.3390/cancers15072166 contributor: fullname: Pinot – volume: 43 start-page: 33 year: 2016 ident: 10.1016/j.ijrobp.2023.10.004_bib0031 article-title: Estimating lung ventilation directly from 4D CT Hounsfield unit values publication-title: Med Phys doi: 10.1118/1.4937599 contributor: fullname: Kipritidis – volume: 15 start-page: 114 year: 2016 ident: 10.1016/j.ijrobp.2023.10.004_bib0027 article-title: Ga-68 MAA perfusion 4D-PET/CT scanning allows for functional lung avoidance using conformal radiation therapy planning publication-title: Technol Cancer Res Treat doi: 10.1177/1533034614565534 contributor: fullname: Siva – volume: 33 start-page: 157 year: 2010 ident: 10.1016/j.ijrobp.2023.10.004_bib0026 article-title: Patterns of recurrence after curative-intent radiation for oligometastases confined to one organ publication-title: Am J Clin Oncol doi: 10.1097/COC.0b013e3181979238 contributor: fullname: Milano – volume: 85 start-page: 636 year: 2012 ident: 10.1016/j.ijrobp.2023.10.004_bib0007 article-title: Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours publication-title: Br J Radiol doi: 10.1259/bjr/71635286 contributor: fullname: Takeda – volume: 24 start-page: 492 year: 1997 ident: 10.1016/j.ijrobp.2023.10.004_bib0025 article-title: Second lung cancers in patients successfully treated for lung cancer publication-title: Semin Oncol contributor: fullname: Johnson – volume: 46 start-page: 428 year: 2016 ident: 10.1016/j.ijrobp.2023.10.004_bib0016 article-title: 68Ga PET ventilation and perfusion lung imaging-current status and future challenges publication-title: Semin Nucl Med doi: 10.1053/j.semnuclmed.2016.04.007 contributor: fullname: Bailey – volume: 12 start-page: 219 year: 2017 ident: 10.1016/j.ijrobp.2023.10.004_bib0024 article-title: Risk of second primary malignancies in lung cancer survivors—The influence of different treatments publication-title: Target Oncol doi: 10.1007/s11523-016-0459-0 contributor: fullname: Su – volume: 83 start-page: 878 year: 2012 ident: 10.1016/j.ijrobp.2023.10.004_bib0003 article-title: Oligometastases treated with stereotactic body radiotherapy: Long-term follow-up of prospective study publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2011.08.036 contributor: fullname: Milano – volume: 303 start-page: 1070 year: 2010 ident: 10.1016/j.ijrobp.2023.10.004_bib0005 article-title: Stereotactic body radiation therapy for inoperable early stage lung cancer publication-title: JAMA doi: 10.1001/jama.2010.261 contributor: fullname: Timmerman – volume: 11 year: 2021 ident: 10.1016/j.ijrobp.2023.10.004_bib0029 article-title: Lung function after stereotactic body radiation therapy for early-stage non-small cell lung cancer, changes and predictive markers publication-title: Front Oncol doi: 10.3389/fonc.2021.674731 contributor: fullname: Berg – volume: 110 start-page: 172 year: 2021 ident: 10.1016/j.ijrobp.2023.10.004_bib0008 article-title: Organs at risk considerations for thoracic stereotactic body radiation therapy: What is safe for lung parenchyma? publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2018.11.028 contributor: fullname: Spring Kong – volume: 15 start-page: 1726 year: 2023 ident: 10.1016/j.ijrobp.2023.10.004_bib0006 article-title: A feasibility study of functional lung volume preservation during stereotactic body radiotherapy guided by gallium-68 perfusion PET/CT publication-title: Cancers doi: 10.3390/cancers15061726 contributor: fullname: Lucia – volume: 393 start-page: 2051 year: 2019 ident: 10.1016/j.ijrobp.2023.10.004_bib0002 article-title: Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial publication-title: Lancet doi: 10.1016/S0140-6736(18)32487-5 contributor: fullname: Palma – volume: 96 start-page: 422 year: 2016 ident: 10.1016/j.ijrobp.2023.10.004_bib0021 article-title: Multi-institutional validation study of commercially available deformable image registration software for thoracic images publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2016.05.012 contributor: fullname: Kadoya – volume: 7 year: 2022 ident: 10.1016/j.ijrobp.2023.10.004_bib0010 article-title: Symptomatic radiation pneumonitis after stereotactic body radiation therapy for multiple pulmonary oligometastases or synchronous primary lung cancer publication-title: Adv Radiat Oncol contributor: fullname: Kishi – volume: 46 start-page: 1596 year: 2019 ident: 10.1016/j.ijrobp.2023.10.004_bib0013 article-title: Independent and incremental value of ventilation/perfusion PET/CT and CT pulmonary angiography for pulmonary embolism diagnosis: results of the PECAN pilot study publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-019-04338-z contributor: fullname: Le Roux – volume: 89 start-page: 350 year: 2015 ident: 10.1016/j.ijrobp.2023.10.004_bib0030 article-title: Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: A prospective study publication-title: Lung Cancer doi: 10.1016/j.lungcan.2015.06.019 contributor: fullname: Ferrero – ident: 10.1016/j.ijrobp.2023.10.004_bib0023 – volume: 102 start-page: 1255 year: 2018 ident: 10.1016/j.ijrobp.2023.10.004_bib0028 article-title: Correlation of functional lung heterogeneity and dosimetry to radiation pneumonitis using perfusion SPECT/CT and FDG PET/CT imaging publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2018.05.051 contributor: fullname: Lee – volume: 83 start-page: e545 year: 2012 ident: 10.1016/j.ijrobp.2023.10.004_bib0009 article-title: Dose-volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2012.01.018 contributor: fullname: Matsuo – volume: 26 start-page: 59 year: 2022 ident: 10.1016/j.ijrobp.2023.10.004_bib0018 article-title: Organs at risk radiation dose constraints publication-title: Cancer Radiother doi: 10.1016/j.canrad.2021.11.001 contributor: fullname: Noël – volume: 56 start-page: 1718 year: 2015 ident: 10.1016/j.ijrobp.2023.10.004_bib0015 article-title: Correlation of 68Ga ventilation-perfusion PET/CT with pulmonary function test indices for assessing lung function publication-title: J Nucl Med doi: 10.2967/jnumed.115.162586 contributor: fullname: Le Roux – volume: 8 year: 2021 ident: 10.1016/j.ijrobp.2023.10.004_bib0011 article-title: Radiation therapy planning of thoracic tumors: A review of challenges associated with lung toxicities and potential perspectives of gallium-68 lung PET/CT imaging publication-title: Front Med (Lausanne) contributor: fullname: Lucia – volume: 15 start-page: 518 year: 2022 ident: 10.1016/j.ijrobp.2023.10.004_bib0019 article-title: Radiopharmaceutical labelling for lung ventilation/perfusion PET/CT imaging: A review of production and optimization processes for clinical use publication-title: Pharmaceuticals (Basel) doi: 10.3390/ph15050518 contributor: fullname: Blanc-Béguin – volume: 52 start-page: 1513 year: 2011 ident: 10.1016/j.ijrobp.2023.10.004_bib0014 article-title: 68Ga PET/CT ventilation-perfusion imaging for pulmonary embolism: A pilot study with comparison to conventional scintigraphy publication-title: J Nucl Med doi: 10.2967/jnumed.111.093344 contributor: fullname: Hofman – volume: 41 start-page: 202 year: 2014 ident: 10.1016/j.ijrobp.2023.10.004_bib0022 article-title: SU-E-J-198: Evaluation of a free-form intensity-based deformable registration method using the POPI model publication-title: Med Phys doi: 10.1118/1.4888251 contributor: fullname: Nelson – volume: 20 start-page: 494 year: 2019 ident: 10.1016/j.ijrobp.2023.10.004_bib0001 article-title: Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): A phase 3, open-label, randomised controlled trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(18)30896-9 contributor: fullname: Ball – volume: 182 year: 2023 ident: 10.1016/j.ijrobp.2023.10.004_bib0032 article-title: Metrics of dose to highly ventilated lung are predictive of radiation-induced pneumonitis in lung cancer patients publication-title: Radiother Oncol doi: 10.1016/j.radonc.2023.109553 contributor: fullname: Flakus – volume: 129 start-page: 196 year: 2018 ident: 10.1016/j.ijrobp.2023.10.004_bib0012 article-title: Functional lung imaging in radiation therapy for lung cancer: A systematic review and meta-analysis publication-title: Radiother Oncol doi: 10.1016/j.radonc.2018.07.014 contributor: fullname: Bucknell – volume: 49 start-page: 71 year: 2019 ident: 10.1016/j.ijrobp.2023.10.004_bib0017 article-title: PET/CT lung ventilation and perfusion scanning using Galligas and gallium-68-MAA publication-title: Semin Nucl Med doi: 10.1053/j.semnuclmed.2018.10.013 contributor: fullname: Le Roux |
SSID | ssj0001174 |
Score | 2.5005367 |
Snippet | The aim of this work was to compare anatomic and functional dose-volume parameters as predictors of acute radiation-induced lung toxicity (RILT) in patients... PURPOSEThe aim of this work was to compare anatomic and functional dose-volume parameters as predictors of acute radiation-induced lung toxicity (RILT) in... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 952 |
Title | Prediction of Acute Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy Using Dose-Volume Parameters From Functional Mapping on Gallium 68 Perfusion Positron Emission Tomography/Computed Tomography |
URI | https://dx.doi.org/10.1016/j.ijrobp.2023.10.004 https://www.ncbi.nlm.nih.gov/pubmed/37875246 https://search.proquest.com/docview/2881710657 |
Volume | 118 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELb2IQEXxJvykpG4RSlN4qTpsUCrFdsuaOlCb1FiOyLVtl51G4nyV_kzzNhJnFVZsXCJqpFsRZ0vM5_H8yDkjfRkHucec3MJRxQmM-Gmg0C4QuhRt2HQy7B2eHoSHZ2xj_Nwvrd_u5W1VG6yLv_5x7qS_9EqyECvWCX7D5ptNgUB_Ab9whM0DM8b6fjzGq9Zas435Hjnf4rNBlDk4lQOvN2fwPfszNSPgiPjHuqh4F_gIdVGV0g575TY2nWYhIGNBhyTTfBBXUr3q7ZhQDcxlQv7cQLhVUtnDE6xiiVO0wtdeYVNOtLz86JcOlGM-fV5ifE4HApcYNTdGQGwtGSmllW7bOzRa4ZLiJa0TZuvxi1b3S7WzVurFW8KbzJbg2MiN83BYVJykx2MhF0nCfRVYW8KYONqPnMr1x_8RrFS2llhs-OtNdrLrd5rqr7D3yLaARSfYQaZKSHtSmP04_7ABd41v-IVrFuwMQ9t4wem5W5FFwbGmex4IhMUWXSLxVpl2BjVD7o6jZBZz1tnG5x8SsZnk0kyG81n--TQB5sJxvpweHz67bihFR6cHevaT52guLvzddzqurOT5lCze-RudfihQ4Pk-2RPrh6QW9MqveMh-WUBTVVONaDpDqApAprWgKYa0LQNaIqAtutoBWiqAU1bgKYW0BQBTS2gaQVoCusrQNMopg2gaQ1oWgOaWui-reHckj0iZ-PR7P2RW00fcXkQ9jdulAeelws_FFxHJXgEbLuXp54EryXSVHhRmgcZ76WM9VIuox5nPIqFEIEv8zQLHpODlVrJp4TykPkiiPt-JgSTkqVZFjGZ80BEYMi9uEPcWm_JhWkyk9TZl4vE6DlBPaMU9Nwh_Vq5SUWUDQFOAH1_Wfm6xkIC_w5eDqYrqcrLxI9jD04bUdjvkCcGJM27BODVQ59Fz26w-jm5Yz-yF-Rgsy7lS-Dtm-xVhejfdM8Ajg |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prediction+of+Acute+Radiation-Induced+Lung+Toxicity+After+Stereotactic+Body+Radiation+Therapy+Using+Dose-Volume+Parameters+From+Functional+Mapping+on+Gallium+68+Perfusion+Positron+Emission+Tomography%2FComputed+Tomography&rft.jtitle=International+journal+of+radiation+oncology%2C+biology%2C+physics&rft.au=Lucia%2C+Fran%C3%A7ois&rft.au=Bourhis%2C+David&rft.au=Pinot%2C+Fanny&rft.au=Hamya%2C+Mohamed&rft.date=2024-03-15&rft.eissn=1879-355X&rft.volume=118&rft.issue=4&rft.spage=952&rft.epage=962&rft_id=info:doi/10.1016%2Fj.ijrobp.2023.10.004&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0360-3016&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0360-3016&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0360-3016&client=summon |